EUCTR2008-006772-30-AT进行中（未招募）1 期
Evaluation of HCV clearance by hemodialysis
Medical University of Graz0 个研究点开始时间: 2009年2月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Consecutive hemodialysed patients with end-stage renal disease and documented presence of HCV RNA in serum over a period of ?6 months
- •- Age >18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- HCV/HBV or HCV/HIV co-infection
- •- Hematologic disease
- •- Pregnancy
研究者
相似试验
已完成
不适用
Surveillance of HCV in Uremics and Linking to Medical CareHepatitis CNCT03803410Kaohsiung Medical University Chung-Ho Memorial Hospital2,973
已完成
不适用
High cut-off Continuous venovenous haemodialysis (CVVHD) to improve haemodynamic stability and Organ function scores in patients treated for acute renal failure after Systemic inflammatory response Syndrome (SIRS)/septic shockAcute renal failure after SIRS/septic shockUrological and Genital DiseasesRenal failureISRCTN77656437Gambro Dialysatoren GmbH (Germany)120
已完成
4 期
EBR/GZR for HCV-1b Patients Receiving HemodialysisHepatitis CNCT03420300National Taiwan University Hospital40
已完成
2 期
Continuous Hemodialysis With an Enhanced Middle Molecule Clearance MembraneSeptic ShockNCT01067313Fresenius Medical Care France24
已完成
4 期
Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose RibavirinChronic Hepatitis CHemodialysisNCT00491179National Taiwan University Hospital35